Other Names
avalanche lilyErythronium grandiflorum var. multiflorum Torr.Erythronium purpurascens S. WatsonErythronium purpurascens var. uniflorum S. Watsonplain leaf fawn lilypurple fawn lilypurple fawnlilySierra Nevada fawn lily
Erythronium purpurascens S. Watson is a species of flowering plant in the lily family (Liliaceae), known by the common names purple fawn lily and Sierra Nevada fawn lily. The species was formally described by Sereno Watson and the accepted name, Erythronium purpurascens S. Watson [family LILIACEAE], is treated in the Flora of North America, Volume 26, with authorship by Geraldine A. Allen and Kenneth R. Robertson. The original publication of the name appeared in the Proceedings of the American Academy of Arts and Sciences 12: 277 (1877). A synonym recognized in earlier botanical literature is Erythronium grandiflorum var. multiflorum Torr., as well as the infraspecific taxon Erythronium purpurascens var. uniflorum S. Watson, published in Watson & al., Bot. California 2: 171 (1880).
The genus Erythronium is placed in the order Liliales, family Liliaceae. The genus name Erythronium derives from the Ancient Greek ἐρυθρός (eruthrós), meaning "red," referring to the red flowers of E. dens-canis, the type species. Erythronium currently includes 33 accepted species of hardy spring-flowering perennial plants with long, tooth-like bulbs. Within the broader order, the genus is most closely related to tulips, and its name refers to the red flowers of E. dens-canis.
There are no established synonyms in wide current use specific to E. purpurascens beyond those noted above, and the name is accepted by the major international plant databases including Kew's Plants of the World Online (POWO), the USDA PLANTS Database, and the Jepson eFlora of California.
This mountain wildflower grows from a bulb 2 to 4 centimeters long and produces two narrow green leaves up to 15 centimeters in length. The erect stalks reach a maximum of 20 centimeters tall and each bears one to six flowers. The flower has white tepals with yellow bases, which turn purple with age. Each tepal is only one or two centimeters long and curls back. The stamens are 8–12 mm; filaments are yellow and slender; anthers are cream to yellow; the style is yellow, 4–5 mm; and the stigma is essentially unlobed.
It is endemic to California, where it grows in the high mountains of the southern Cascade Range, Coast Ranges, and northern Sierra Nevada, from Siskiyou County south to Mendocino and Placer Counties. It is a bulb-forming plant growing to approximately 0.3 m, is not frost tender, and flowers from April to May, with seeds ripening from June to July. It is suitable for light (sandy) and medium (loamy), well-drained soils at mildly acid to mildly alkaline pH and can grow in semi-shade; it prefers moist soil. Characteristic habitats include Yellow Pine Forest and Red Fir Forest communities. The flowers bloom as the last snow is melting, which may not be until summer at higher elevations.
Erythronium purpurascens S. Watson is a perennial herb (bulb) that is native to California and endemic (limited) to California. Because it is a narrow Californian endemic with limited population sizes, the species is tracked by conservation authorities; like many narrow endemics, endemic taxa are at greater risk than non-endemics, with 90% of endemic taxa in California considered vulnerable to extinction.
Erythronium purpurascens is not currently produced as a commercially standardized dietary supplement, nor is it listed in any recognized pharmacopeia, regulatory monograph, or official health-body ingredient database. It does not appear in the NIH Office of Dietary Supplements databases, the NCCIH herb index, the WHO monograph series, the European Medicines Agency (EMA) herbal monographs, ESCOP monographs, the German Commission E, or any EFSA opinion. As a consequence, there are no official or standardized dosage forms, extracts, or preparations for this species in the supplement market. The bulb is the plant part most commonly referenced in genus-level ethnobotanical literature as a food source. The bulb is edible as a root vegetable, cooked or dried, and can be ground into flour; the leaves can also be cooked as a leaf vegetable.
Of all established Erythronium species, most live in North America; only seven species are found in Europe and Asia. The genus can be divided into two sub-genera — one comprising E. dens-canis and the eastern American species, the other comprising the western erythroniums native to the Pacific Slope of North America — and as a genus, Erythronium is most closely related to Tulipa. The western North American species, which include E. purpurascens, those from montane meadows and willow thickets have green leaves, summer flowers, and are dormant in winter.
It is important to state clearly at the outset that the ethnobotanical and historical use literature is far richer for other members of the genus — particularly E. americanum (trout lily), E. albidum (white trout lily), E. grandiflorum (glacier lily), and the Eurasian E. dens-canis (dog's-tooth violet) — than it is for E. purpurascens. No dedicated ethnobotanical study specifically documenting traditional uses of E. purpurascens by California Indigenous peoples was located in the peer-reviewed literature during this research. The following section therefore clearly distinguishes between what is directly documented for E. purpurascens and what is contextually documented for closely related species within the same genus.
Although no specific mention has been found for this species in most ethnobotanical records, most if not all members of the genus provide edible bulbs; the slender bulb of E. purpurascens is up to 4 cm long. The plant's geographic range — restricted to mountain habitats in northern and central California at elevations associated with late snowmelt — overlaps with the traditional territories of several California Indigenous peoples, including Maidu, Wintu, and Konkow groups, but no primary ethnobotanical source specifically documenting E. purpurascens use by named California groups was retrieved through this research.
To place E. purpurascens in its broader cultural context, the following documents use of related species, each of which is a distinct taxon and whose uses cannot be assumed to apply to E. purpurascens without species-specific evidence.
Erythronium grandiflorum (Glacier Lily): Among the Native American tribes of Montana, Erythronium grandiflorum, commonly known as glacier lily, is utilized as a food source and as a treatment for an affliction of boils. A 1985 study published in the context of Native American food and medicinal plants documented the isolation of alpha-methylene butyrolactone from Erythronium grandiflorum Pursh, linking this compound to the plant's biological activity.
Erythronium americanum (Trout Lily): The Cherokee used the juice from warmed leaves for wounds and an infusion of the root for fever; the Iroquois used a poultice of smashed roots for swellings. All parts of the plant, but especially the bulb and the fresh leaves, are strongly emetic and are not used internally; the fresh leaves are also antiscrofulatic and emollient and are used as an infusion or stimulating poultice applied to swellings, tumors, and scrofulous ulcers. The juice from crushed leaves has been applied to wounds that are not healing, and a poultice of crushed bulbs has been applied to swellings and to help remove splinters.
Erythronium albidum (White Trout Lily): Little is known of the constituents, as little research has been done; it is known to contain α-methylene butyrolactone; the plant is emetic, emollient, and antiscorbutic when fresh; it is nutritive when dry; certain groups of Native Americans used it for its emetic and contraceptive properties; Onondaga women used the leaves as a temporary birth control method in spring, to avoid giving birth in the most frigid part of winter. The fresh leaves are mostly used in the form of a stimulating poultice, applied to swellings, tumors, and scrofulous ulcers; when made into a tea with horsetail (Equisetum hyemale), it is claimed to be good for bleeding or ulcers of bowels, or for tumors and inflammation of the bowels.
Erythronium revolutum (Pink Fawn Lily): This closely related Pacific Northwest species is an edible plant; its scaly corms were eaten by many groups of Native Americans; they have a bitter, milky taste, but are also cool and moist inside and were enjoyed as a refreshing food for hot days.
Japan — Erythronium japonicum (Katakuri): In Japan, Erythronium japonicum is called katakuri, and the bulb is processed to produce starch. This represents one of the most extensive historical food uses within the genus — as a starch source in traditional Japanese cuisine — but involves a taxonomically distinct Asian species with no botanical relationship to the Californian E. purpurascens.
No peer-reviewed phytochemical analysis of Erythronium purpurascens specifically was identified in this review. The following discussion therefore presents constituent information available for the genus, clearly noting the species studied. Extrapolation to E. purpurascens is scientifically unverified at this time.
The most studied bioactive compound identified in Erythronium species is α-methylene butyrolactone, also known as tulipalin A. Cavallito and Haskell first reported isolation of α-methylene butyrolactone from Erythronium americanum, published in the Journal of the American Chemical Society 68:2332–2334. Subsequently, the compound was also identified from Erythronium grandiflorum Pursh, in the context of Native American food and medicinal plants research. In Erythronium albidum, the plant is known to contain α-methylene butyrolactone, and the plant is emetic, emollient, and antiscorbutic when fresh.
α-Methylene butyrolactone belongs to the class of α-methylene-γ-butyrolactones, a family of sesquiterpene lactone-related compounds found across multiple plant families. This compound has been identified as a fungitoxic substance, with parallel documentation from related tulip (Tulipa) species. The compound is a reactive Michael acceptor, capable of covalently binding to biological nucleophiles including thiol groups on proteins and glutathione. This chemical reactivity underlies both potential bioactivity and the well-documented irritant and sensitizing properties associated with this class of molecule. No species-specific quantitative phytochemical data for E. purpurascens are available in the peer-reviewed literature.
The irritant and allergenic properties of related flower bulb plants are well-described in the medical literature; the tulip, for example, contains the allergen tulipalin A (α-methylene butyrolactone), which causes sensitization and irritation in occupationally exposed individuals. Because Erythronium is closely related to Tulipa and members of the genus have been documented to contain the same compound, the potential for similar sensitizing properties in E. purpurascens is biologically plausible, though it has not been specifically investigated.
Based on characterization of other western North American Erythronium species and the broader Liliaceae family, the expected secondary metabolite profile of E. purpurascens would potentially include:
All constituent claims beyond α-methylene butyrolactone remain hypothetical for this specific species in the absence of dedicated phytochemical study.
There are no published human clinical trials, controlled trials, systematic reviews, or meta-analyses examining Erythronium purpurascens as a dietary supplement, therapeutic agent, or health intervention. Furthermore, no animal studies, in vitro pharmacological studies, or mechanistic studies specifically using Erythronium purpurascens material were identified in any peer-reviewed database during this research. The following summaries therefore address evidence for the most commonly discussed properties attributed to the genus at large, noting the species and limitations of each study.
One source cautions that all parts of Erythronium plants, including the bulb and fresh leaves, are strongly emetic and should not be used internally. This emetic effect is attributed by multiple sources to the presence of α-methylene butyrolactone and possibly other reactive compounds, and is broadly consistent across accounts of E. americanum, E. albidum, and to some degree other North American species. The mechanism is presumed to involve gastrointestinal mucosal irritation by the reactive lactone moiety, though this has not been formally characterized in controlled pharmacological studies for any Erythronium species. Evidence level: anecdotal/ethnobotanical only; no controlled studies.
α-Methylenebutyrolactone has been identified as a fungitoxic substance from related bulb plants. Given the documentation of this compound in closely related Erythronium species, its presence in E. purpurascens is biologically plausible, but has not been demonstrated. Evidence level: in vitro data for the isolated compound from related species only; no species-specific or in vivo studies for E. purpurascens.
For related species, the fresh leaves of E. americanum are used as a stimulating poultice applied to swellings, tumors, and scrofulous ulcers, and the juice from crushed leaves has been applied to wounds that are not healing. No pharmacological mechanism has been established for these effects, and no controlled evidence exists for E. purpurascens or any Erythronium species in this area. Evidence level: traditional use records only; no clinical or experimental data.
The bulb is edible as a root vegetable, cooked or dried, and can be ground into flour; the leaves can also be cooked as a leaf vegetable. Trout lilies have limited uses as food; several sources suggest that the very young leaves or corms can be used as a cooked vegetable, but advise limiting harvesting to large colonies. No macronutrient, micronutrient, or bioactive constituent analysis specific to E. purpurascens has been published. Evidence level: ethnobotanical documentation of food use in related species; no nutritional analysis for E. purpurascens.
In summary, Erythronium purpurascens has no documented scientific evidence base in the form of human clinical studies, animal studies, or dedicated in vitro research. Its use as a dietary supplement or medicinal ingredient lacks the foundational preclinical characterization that would ordinarily precede clinical investigation. The compound class most associated with the genus (α-methylene butyrolactones) is known primarily for its irritant and skin-sensitizing properties, and for fungitoxic activity, rather than for health-promoting effects.
Based exclusively on the traditional use records of closely related species documented in the ethnobotanical literature, the following body systems and health contexts are associated with the broader Erythronium genus. None of these associations has been validated by clinical studies, and none can be attributed to E. purpurascens specifically without species-level evidence.
No standardized dosage forms or dosages for Erythronium purpurascens are reported in any peer-reviewed study, pharmacopeial monograph, or regulatory body document. The species is not included in any official ingredient list, supplement product database, or pharmacopeia. Consequently, no dosage information can be provided for this species without risking fabrication.
For context on genus-level food use: most if not all members of the genus provide edible bulbs; the slender bulb of E. purpurascens is up to 4 cm long. Anyone trying even well-known edible varieties of Erythronium should start slowly and keep portions small; some species are reported to have emetic effects at high doses. These are not therapeutic dosages and represent informal food-safety observations only.
All parts of the plant, including the bulb and fresh leaves, are strongly emetic and should not be used internally, according to sources documenting E. americanum. Plants in this genus are emetic, emollient, and antiscorbutic when fresh, and nutritive when dry. The emetic property is broadly attributed across the genus and likely applies to E. purpurascens given shared phytochemistry, though this has not been formally confirmed. The mechanism is consistent with the known irritant properties of α-methylene butyrolactone.
Skin contact with the corms of Erythronium species has been known to cause dermatitis in sensitive individuals. This is biologically consistent with the presence of α-methylene butyrolactone (tulipalin A), a well-documented contact allergen and sensitizer in related members of the Liliaceae/Liliiflorae. The irritant and allergenic properties of related flower bulbs (including tulips, which contain tulipalin A) are well-described, causing sensitization and irritation. Occupational and non-occupational sensitization via repeated skin contact with bulbs is a recognized phenomenon within this plant family.
As a perennial herb that is native to and endemic (limited) to California, growing in the high mountains of the southern Cascade Range, Coast Ranges, and northern Sierra Nevada, Erythronium purpurascens has a highly restricted range. Its status as a California endemic with limited and fragmented populations means that wild collection would raise significant conservation concerns. No cultivated or commercially supplied material is documented in the supplement trade literature.
No formal toxicology studies — including acute toxicity, subchronic toxicity, genotoxicity, reproductive toxicity, or drug interaction studies — have been conducted for Erythronium purpurascens. No adverse event reports, case reports, or pharmacovigilance data were identified in any medical database or regulatory document. The absence of safety data must itself be considered a significant safety-relevant finding for any prospective user or researcher.
No studies or case reports documenting drug interactions involving Erythronium purpurascens were identified. The reactive alkylating chemistry of α-methylene butyrolactone compounds (the compound class known from related species) suggests theoretical potential for interactions mediated through glutathione depletion or protein alkylation, but this has not been studied for this species.
Erythronium purpurascens is not recognized as a dietary supplement ingredient by any authoritative regulatory body. It does not appear in the NIH Office of Dietary Supplements ingredient databases, the NCCIH herb index, the EMA list of herbal substances, any WHO monograph, or any pharmacopeia. It carries no regulatory status under European food supplement law (EFSA, Novel Food Regulation) or U.S. dietary supplement law (DSHEA). Its availability as a commercial supplement ingredient is unknown from the available scientific and regulatory literature.
Erythroniums are widely grown as ornamental plants, with numerous hybrids and cultivars having been selected for garden use, suggesting the genus's primary contemporary role outside of its native range is horticultural rather than medicinal or nutritional.
Erythronium purpurascens (purple fawn lily / Sierra Nevada fawn lily) is a narrowly endemic California wildflower, formally described in 1877, that belongs to a genus with some traditional food and ethnomedicinal significance in North America. However, it lacks any species-specific phytochemical characterization, pharmacological study, or clinical investigation in the peer-reviewed literature. There are no human clinical trials, no animal studies, no validated safety data, and no official monographs of any kind for this specific species.
The compound class most robustly associated with related Erythronium species — α-methylene butyrolactone (tulipalin A) — is primarily known as an irritant, contact sensitizer, and fungitoxic agent, rather than as a health-promoting substance. Fresh plant material from genus members is broadly characterized as strongly emetic. The species' endemic status, restricted geographic range, and lack of cultivation infrastructure for supplement supply further limit its realistic accessibility as an ingredient.
Any characterization of Erythronium purpurascens as a dietary supplement or natural health ingredient with defined health benefits, dosages, or mechanisms of action is not supportable by the current scientific literature. Substantial foundational research — including phytochemical characterization, preclinical toxicology, and pharmacological screening — would be required before any evidence-based assessment of therapeutic potential could be made.
Health conditions that Erythronium purpurascens may help support.
Body systems that Erythronium purpurascens may help support.